ARTICLE | Company News
CytoGenix, Endovasc deal
September 17, 2001 7:00 AM UTC
ENDV will use its liposome technology to encapsulate CYGX's single-strand DNA (ssDNA) expression system to improve targeting and cellular uptake. CytoGenix uses its ssDNA technology for therapeutic an...